Spatiotemporally controllable diphtherin transgene system and neoantigen immunotherapy-Reference-Cited by-同舟云学术

Spatiotemporally controllable diphtherin transgene system and neoantigen immunotherapy

Published:2023-03 Issue: Volume:355 Page:538-551
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

He Muye,Sun Yuji,Cheng Yi,Wang Jie,Zhang Miao,Sun Rui,Hou Xinyu,Xu Jiajun,He Hai,Wang Hongtao,Yuan Zeting,Lan Minbo,Zhao Yuzheng,Yang Yi,Chen Xianjun,Gao Feng

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference36 articles.

1. Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets;Stanton;Vaccine,2019

2. Development of HPV 16,18,31,45 E5 and E7 peptides-based vaccines predicted by immunoinformatics tools;Namvar;Biotechnol. Lett.,2020

3. Rationally designed DNA-based nanocarriers;Jiang;Adv. Drug Deliv. Rev.,2019

4. Combination immunotherapy of MUC1 mRNA nano-vaccine and CTLA-4 blockade effectively inhibits growth of triple negative breast Cancer;Liu;Mol. Ther.,2018

5. Recent advances in anti-cancer protein/peptide delivery;Liu;Bioconjug. Chem.,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tat-dependent conditionally replicating adenoviruses expressing diphtheria toxin A for specifically killing HIV-1-infected cells;Molecular Therapy;2024-07

2. ROS-responsive nano-medicine for navigating autophagy to enhance targeted therapy of inflammatory bowel disease;International Journal of Pharmaceutics;2024-06

3. Regulation of Antigen‐Specific Immunotherapy with Nanomaterials;Advanced NanoBiomed Research;2023-11-27

4. Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast Cancer Metastasis Inhibition;ACS Applied Materials & Interfaces;2023-11-09

5. Facile preparation of PEGylated polyethylenimine polymers as vaccine carriers with reduced cytotoxicity and enhanced Interleukin-2 (IL-2) production;Colloids and Surfaces B: Biointerfaces;2023-10